Treatment outcomes in childhood acute lymphoblastic leukemia: 40-year experience from a single tertiary center in Thailand

References

• Ward E, DeSantis C, Robbins A, Kohler B, Jemal A. Childhood and adolescent cancer statistics, 2014. CA Cancer J Clin. 2014;64(2):83–103. doi:10.3322/caac.21219.
   PubMed Web of Science ®Google Scholar
• Ross JA, Spector LG. Cancers in Children. In: Schottenfeld, D, Fraumeni, JF, eds. Ca Epidemiology and Prevention. New York: Oxford University Press, Inc; 2006:1251–1268.
   Google Scholar
• Pui CH, Evans WE. Acute lymphoblastic leukemia. N Engl J Med. 1998;339(9):605–615. doi:10.1056/NEJM199808273390907.
   PubMed Web of Science ®Google Scholar
• Demanelis K, Sriplung H, Meza R, et al. Differences in childhood leukemia incidence and survival between Southern Thailand and the United States: a population-based analysis. Pediatr Blood Cancer. 2015;62(10):1790–1798. doi:10.1002/pbc.25571.
   PubMed Web of Science ®Google Scholar
• Bidwell SS, Peterson CC, Demanelis K, et al. Childhood cancer incidence and survival in Thailand: A comprehensive population-based registry analysis, 1990-2011. Pediatr Blood Cancer. 2019;66(1):e27428. doi:10.1002/pbc.27428.
   PubMed Web of Science ®Google Scholar
• Pui CH, Evans WE. Treatment of acute lymphoblastic leukemia. N Engl J Med. 2006;354(2):166–178. doi:10.1056/NEJMra052603.
   PubMed Web of Science ®Google Scholar
• Pui CH. Acute lymphoblastic leukemia in children. Curr Opin Oncol. 2000;12(1):3–12. doi:10.1097/00001622-200001000-00002.
   PubMed Web of Science ®Google Scholar
• Silverman LB, Gelber RD, Dalton VK, et al. Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91-01. Blood. 2001;97(5):1211–1218. doi:10.1182/blood.v97.5.1211.
   PubMed Web of Science ®Google Scholar
• Schmiegelow K, Forestier E, Hellebostad M, et al. Long-term results of NOPHO ALL-92 and ALL-2000 studies of childhood acute lymphoblastic leukemia. Leukemia. 2010;24(2):345–354. doi:10.1038/leu.2009.251.
   PubMed Web of Science ®Google Scholar
• Inaba H, Mullighan CG. Pediatric acute lymphoblastic leukemia. Haematologica. 2020;105(11):2524–2539. doi:10.3324/haematol.2020.247031.
   PubMed Web of Science ®Google Scholar
• Mitchell C, Payne J, Wade R, et al. The impact of risk stratification by early bone-marrow response in childhood lymphoblastic leukaemia: results from the United Kingdom Medical Research Council trial ALL97 and ALL97/99. Br J Haematol. 2009;146(4):424–436. doi:10.1111/j.1365-2141.2009.07769.x.
   PubMed Web of Science ®Google Scholar
• Mehta PA, Davies SM. Allogeneic transplantation for childhood ALL. Bone Marrow Transplant. 2008;41(2):133–139. doi:10.1038/sj.bmt.1705914.
   PubMed Web of Science ®Google Scholar
• Veerman AJ, Kamps WA, van den Berg H, et al. Dexamethasone-based therapy for childhood acute lymphoblastic leukaemia: results of the prospective Dutch Childhood Oncology Group (DCOG) protocol ALL-9 (1997-2004). Lancet Oncol. 2009;10(10):957–966. doi:10.1016/S1470-2045(09)70228-1.
   PubMed Web of Science ®Google Scholar
• Laosombat V, Wongchanchailert M, Sattayasevana B, Wiriyasateinkul A, Watana-Arepornchai S. The treatment of children with acute lymphoblastic leukemia in Thailand. Med Pediatr Oncol. 2002;38(4):266–268. doi:10.1002/mpo.1321.
   PubMedGoogle Scholar
• Navarrete M, Rossi E, Brivio E, et al. Treatment of childhood acute lymphoblastic leukemia in central America: a lower-middle income countries experience. Pediatr Blood Cancer. 2014;61(5):803–809. doi:10.1002/pbc.24911.
   PubMed Web of Science ®Google Scholar
• Seksarn P, Wiangnon S, Veerakul G, Chotsampancharoen T, Kanjanapongkul S, Chainansamit SO. Outcome of childhood acute lymphoblastic leukemia treated using the Thai National Protocols. Asian Pac J Cancer Prev. 2015;16(11):4609–4614. doi:10.7314/apjcp.2015.16.11.4609.
   PubMedGoogle Scholar
• Al-Nasser A, El-Solh H, De Vol E, et al. Improved outcome for children with acute lymphoblastic leukemia after risk-adjusted intensive therapy: a single-institution experience. Ann Saudi Med. 2008;28(4):251–259. doi:10.5144/0256-4947.2008.251.
   PubMed Web of Science ®Google Scholar
• Chotsampancharoen T, Sripornsawan P, Duangchu S, Wongchanchailert M, McNeil E. Survival outcome of alternative medicine treatment for newly diagnosed acute leukemia in children. Acta Haematol. 2018;140(4):203–208. doi:10.1159/000493417.
   PubMed Web of Science ®Google Scholar
• Bennett JM, Catovsky D, Daniel MT, et al. Proposals for the classification of the acute leukaemias French-American-British (FAB) Co-operative group. Br J Haematol. 1976;33(4):451–458. doi:10.1111/j.1365-2141.1976.tb03563.x.
   PubMed Web of Science ®Google Scholar
• Harris NL, Jaffe ES, Diebold J, et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. J Clin Oncol. 1999;17(12):3835–3849. doi:10.1200/JCO.1999.17.12.3835.
   PubMed Web of Science ®Google Scholar
• Aur RJ, Simone J, Hustu HO, et al. Central nervous system therapy and combination chemotherapy of childhood lymphocytic leukemia. Blood. 1971;37(3):272–281. https://reader.elsevier.com/reader/sd/pii/S0006497120694587?token=FE52260728DDE6FCEF10B0ABA1B732398311A2B190FA6E220CB4F385D2E683632D67756475390F22C8002907A15C85FD&originRegion=eu-west-1&originCreation=20230310043019
   PubMed Web of Science ®Google Scholar
• Bleyer WA, Sather H, Coccia P, Lukens J, Siegel S, Hammond GD. The staging of childhood acute lymphoblastic leukemia: strategies of the Childrens Cancer Study Group and a three-dimensional technic of multivariate analysis. Med Pediatr Oncol. 1986;14(5):271–280. doi:10.1002/mpo.2950140506.
   PubMedGoogle Scholar
• Gaynon PS, Steinherz PG, Bleyer WA, et al. Intensive therapy for children with acute lymphoblastic leukaemia and unfavourable presenting features. Early conclusions of study CCG-106 by the Childrens Cancer Study Group. Lancet. 1988;2(8617):921–924. doi:10.1016/s0140-6736(88)92596-2.
   PubMed Web of Science ®Google Scholar
• Tubergen DG, Gilchrist GS, O’Brien RT, et al. Improved outcome with delayed intensification for children with acute lymphoblastic leukemia and intermediate presenting features: a Childrens Cancer Group phase III trial. J Clin Oncol. 1993;11(3):527–537. doi:10.1200/JCO.1993.11.3.527.
   PubMed Web of Science ®Google Scholar
• Lauer SJ, Shuster JJ, Mahoney DH, et al. A comparison of early intensive methotrexate/mercaptopurine with early intensive alternating combination chemotherapy for high-risk B-precursor acute lymphoblastic leukemia: a Pediatric Oncology Group phase III randomized trial. Leukemia. 2001;15(7):1038–1045. doi:10.1038/sj.leu.2402132.
   PubMed Web of Science ®Google Scholar
• Hunger SP, Lu X, Devidas M, et al. Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: a report from the children’s oncology group. J Clin Oncol. 2012;30(14):1663–1669. doi:10.1200/JCO.2011.37.8018.
   PubMed Web of Science ®Google Scholar
• Bhojwani D, Yang JJ, Pui CH. Biology of childhood acute lymphoblastic leukemia. Pediatr Clin North Am. 2015;62(1):47–60. doi:10.1016/j.pcl.2014.09.004.
   PubMed Web of Science ®Google Scholar
• Halalsheh H, Abuirmeileh N, Rihani R, Bazzeh F, Zaru L, Madanat F. Outcome of childhood acute lymphoblastic leukemia in Jordan. Pediatr Blood Cancer. 2011;57(3):385–391. doi:10.1002/pbc.23065.
   PubMed Web of Science ®Google Scholar
• Gao YJ, Lu FJ, Wang HS. Treating childhood acute lymphoblastic leukemia in a developing country 1998-2003: the experience of a single children’s hospital in China. J Pediatr Hematol Oncol. 2006;28(12):798–802. doi:10.1097/MPH.0b013e31802d3e7a.
   PubMed Web of Science ®Google Scholar
• Liang DC, Yang CP, Lin DT, et al. Long-term results of Taiwan Pediatric Oncology Group studies 1997 and 2002 for childhood acute lymphoblastic leukemia. Leukemia. 2010;24(2):397–405. doi:10.1038/leu.2009.248.
   PubMed Web of Science ®Google Scholar
• Pui CH, Campana D, Pei D, et al. Treating childhood acute lymphoblastic leukemia without cranial irradiation. N Engl J Med. 2009;360(26):2730–2741. doi:10.1056/NEJMoa0900386.
   PubMed Web of Science ®Google Scholar
• Vora A, Goulden N, Wade R, et al. Treatment reduction for children and young adults with low-risk acute lymphoblastic leukaemia defined by minimal residual disease (UKALL 2003): a randomised controlled trial. Lancet Oncol. 2013;14(3):199–209. doi:10.1016/S1470-2045(12)70600-9.
   PubMed Web of Science ®Google Scholar
• Stary J, Zimmermann M, Campbell M, et al. Intensive chemotherapy for childhood acute lymphoblastic leukemia: results of the randomized intercontinental trial ALL IC-BFM 2002. J Clin Oncol. 2014;32(3):174–184. doi:10.1200/JCO.2013.48.6522.
   PubMed Web of Science ®Google Scholar
• Pui CH, Pei D, Sandlund JT, et al. Long-term results of St Jude Total Therapy Studies 11, 12, 13A, 13B, and 14 for childhood acute lymphoblastic leukemia. Leukemia. 2010;24(2):371–382. doi:10.1038/leu.2009.252.
   PubMed Web of Science ®Google Scholar
• Locatelli F, Schrappe M, Bernardo ME, Rutella S. How I treat relapsed childhood acute lymphoblastic leukemia. Blood. 2012;120(14):2807–2816. doi:10.1182/blood-2012-02-265884.
   PubMed Web of Science ®Google Scholar
• Ko RH, Ji L, Barnette P, et al. Outcome of patients treated for relapsed or refractory acute lymphoblastic leukemia: a therapeutic advances in childhood leukemia Consortium study. J Clin Oncol. 2010;28(4):648–654. doi:10.1200/JCO.2009.22.2950.
   PubMed Web of Science ®Google Scholar
• Pui CH, Mahmoud HH, Rivera GK, et al. Early intensification of intrathecal chemotherapy virtually eliminates central nervous system relapse in children with acute lymphoblastic leukemia. Blood. 1998;92(2):411–415. https://reader.elsevier.com/reader/sd/pii/S0006497120570791?token=85CB1295B55145291B5876E3A1780739697E0F69F167F9C86F988BE6BCBD2B9756B097CC11D1F82421FFD74BA4A13CB0&originRegion=eu-west-1&originCreation=20230310035534
   PubMed Web of Science ®Google Scholar
• Richards S, Pui CH, Gayon P. Childhood Acute Lymphoblastic Leukemia Collaborative Group (CALLCG). Systematic review and meta-analysis of randomized trials of central nervous system directed therapy for childhood acute lymphoblastic leukemia. Pediatr Blood Cancer. 2013;60(2):185–195. doi:10.1002/pbc.24228.
   PubMed Web of Science ®Google Scholar
• Pui CH, Evans WE. A 50-year journey to cure childhood acute lymphoblastic leukemia. Semin Hematol. 2013;50(3):185–196. doi:10.1053/j.seminhematol.2013.06.007.
   PubMed Web of Science ®Google Scholar
• Vrooman LM, Silverman LB. Treatment of Childhood Acute Lymphoblastic Leukemia: Prognostic Factors and Clinical Advances. Curr Hematol Malig Rep. 2016;11(5):385–394. doi:10.1007/s11899-016-0337-y.
   PubMed Web of Science ®Google Scholar
• Mostert S, Sitaresmi MN, Gundy CM, Sutaryo null, Veerman AJP. Influence of socioeconomic status on childhood acute lymphoblastic leukemia treatment in Indonesia. Pediatrics. 2006;118(6):e1600-1606–e1606. doi:10.1542/peds.2005-3015.
   Web of Science ®Google Scholar
• Bhatia S, Landier W, Shangguan M, et al. Nonadherence to oral mercaptopurine and risk of relapse in Hispanic and non-Hispanic white children with acute lymphoblastic leukemia: a report from the children’s oncology group. J Clin Oncol. 2012;30(17):2094–2101. doi:10.1200/JCO.2011.38.9924.
   PubMed Web of Science ®Google Scholar
• Metzger ML, Howard SC, Fu LC, et al. Outcome of childhood acute lymphoblastic leukaemia in resource-poor countries. Lancet. 2003;362(9385):706–708. doi:10.1016/S0140-6736(03)14228-6.
   PubMed Web of Science ®Google Scholar
• Christensen MS, Heyman M, Möttönen M, Zeller B, Jonmundsson G, Hasle H. Treatment-related death in childhood acute lymphoblastic leukaemia in the Nordic countries: 1992-2001. Br J Haematol. 2005;131(1):50–58. doi:10.1111/j.1365-2141.2005.05736.x.
   PubMed Web of Science ®Google Scholar